Medical Care

Global Plasmid CDMO Services Market Research Report 2025

The global market for Plasmid CDMO Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Plasmid CDMO Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Plasmid CDMO Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Plasmid CDMO Services in Biopharmaceutical Company is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Plasmid CDMO Services include GenScript ProBio, PackGene Biotech, Hillgene, Porton Advanced Solutions, Catalent, VectorBuilder, Ubrigene, Charles River Laboratories, Obio Technology (Shanghai), Wacker Biotech US, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Plasmid CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid CDMO Services.
The Plasmid CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasmid CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GenScript ProBio
PackGene Biotech
Hillgene
Porton Advanced Solutions
Catalent
VectorBuilder
Ubrigene
Charles River Laboratories
Obio Technology (Shanghai)
Wacker Biotech US
Biovian
Curia
Lotuslake Biomedical
VGXI
Andelyn Biosciences
Esco Aster
BioCina
Merck
Segment by Type
IIT Grade
IND Grade
Clinical Trial Grade
Commercial Production Grade
Segment by Application
Biopharmaceutical Company
Academic Scientific Research Institution
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmid CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 IIT Grade
1.2.3 IND Grade
1.2.4 Clinical Trial Grade
1.2.5 Commercial Production Grade
1.3 Market by Application
1.3.1 Global Plasmid CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Company
1.3.3 Academic Scientific Research Institution
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid CDMO Services Market Perspective (2020-2031)
2.2 Global Plasmid CDMO Services Growth Trends by Region
2.2.1 Global Plasmid CDMO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Plasmid CDMO Services Historic Market Size by Region (2020-2025)
2.2.3 Plasmid CDMO Services Forecasted Market Size by Region (2026-2031)
2.3 Plasmid CDMO Services Market Dynamics
2.3.1 Plasmid CDMO Services Industry Trends
2.3.2 Plasmid CDMO Services Market Drivers
2.3.3 Plasmid CDMO Services Market Challenges
2.3.4 Plasmid CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid CDMO Services Players by Revenue
3.1.1 Global Top Plasmid CDMO Services Players by Revenue (2020-2025)
3.1.2 Global Plasmid CDMO Services Revenue Market Share by Players (2020-2025)
3.2 Global Plasmid CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Plasmid CDMO Services Revenue
3.4 Global Plasmid CDMO Services Market Concentration Ratio
3.4.1 Global Plasmid CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid CDMO Services Revenue in 2024
3.5 Global Key Players of Plasmid CDMO Services Head office and Area Served
3.6 Global Key Players of Plasmid CDMO Services, Product and Application
3.7 Global Key Players of Plasmid CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid CDMO Services Breakdown Data by Type
4.1 Global Plasmid CDMO Services Historic Market Size by Type (2020-2025)
4.2 Global Plasmid CDMO Services Forecasted Market Size by Type (2026-2031)
5 Plasmid CDMO Services Breakdown Data by Application
5.1 Global Plasmid CDMO Services Historic Market Size by Application (2020-2025)
5.2 Global Plasmid CDMO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Plasmid CDMO Services Market Size (2020-2031)
6.2 North America Plasmid CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Plasmid CDMO Services Market Size by Country (2020-2025)
6.4 North America Plasmid CDMO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid CDMO Services Market Size (2020-2031)
7.2 Europe Plasmid CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Plasmid CDMO Services Market Size by Country (2020-2025)
7.4 Europe Plasmid CDMO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid CDMO Services Market Size (2020-2031)
8.2 Asia-Pacific Plasmid CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Plasmid CDMO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Plasmid CDMO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid CDMO Services Market Size (2020-2031)
9.2 Latin America Plasmid CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Plasmid CDMO Services Market Size by Country (2020-2025)
9.4 Latin America Plasmid CDMO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid CDMO Services Market Size (2020-2031)
10.2 Middle East & Africa Plasmid CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Plasmid CDMO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Plasmid CDMO Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript ProBio
11.1.1 GenScript ProBio Company Details
11.1.2 GenScript ProBio Business Overview
11.1.3 GenScript ProBio Plasmid CDMO Services Introduction
11.1.4 GenScript ProBio Revenue in Plasmid CDMO Services Business (2020-2025)
11.1.5 GenScript ProBio Recent Development
11.2 PackGene Biotech
11.2.1 PackGene Biotech Company Details
11.2.2 PackGene Biotech Business Overview
11.2.3 PackGene Biotech Plasmid CDMO Services Introduction
11.2.4 PackGene Biotech Revenue in Plasmid CDMO Services Business (2020-2025)
11.2.5 PackGene Biotech Recent Development
11.3 Hillgene
11.3.1 Hillgene Company Details
11.3.2 Hillgene Business Overview
11.3.3 Hillgene Plasmid CDMO Services Introduction
11.3.4 Hillgene Revenue in Plasmid CDMO Services Business (2020-2025)
11.3.5 Hillgene Recent Development
11.4 Porton Advanced Solutions
11.4.1 Porton Advanced Solutions Company Details
11.4.2 Porton Advanced Solutions Business Overview
11.4.3 Porton Advanced Solutions Plasmid CDMO Services Introduction
11.4.4 Porton Advanced Solutions Revenue in Plasmid CDMO Services Business (2020-2025)
11.4.5 Porton Advanced Solutions Recent Development
11.5 Catalent
11.5.1 Catalent Company Details
11.5.2 Catalent Business Overview
11.5.3 Catalent Plasmid CDMO Services Introduction
11.5.4 Catalent Revenue in Plasmid CDMO Services Business (2020-2025)
11.5.5 Catalent Recent Development
11.6 VectorBuilder
11.6.1 VectorBuilder Company Details
11.6.2 VectorBuilder Business Overview
11.6.3 VectorBuilder Plasmid CDMO Services Introduction
11.6.4 VectorBuilder Revenue in Plasmid CDMO Services Business (2020-2025)
11.6.5 VectorBuilder Recent Development
11.7 Ubrigene
11.7.1 Ubrigene Company Details
11.7.2 Ubrigene Business Overview
11.7.3 Ubrigene Plasmid CDMO Services Introduction
11.7.4 Ubrigene Revenue in Plasmid CDMO Services Business (2020-2025)
11.7.5 Ubrigene Recent Development
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Details
11.8.2 Charles River Laboratories Business Overview
11.8.3 Charles River Laboratories Plasmid CDMO Services Introduction
11.8.4 Charles River Laboratories Revenue in Plasmid CDMO Services Business (2020-2025)
11.8.5 Charles River Laboratories Recent Development
11.9 Obio Technology (Shanghai)
11.9.1 Obio Technology (Shanghai) Company Details
11.9.2 Obio Technology (Shanghai) Business Overview
11.9.3 Obio Technology (Shanghai) Plasmid CDMO Services Introduction
11.9.4 Obio Technology (Shanghai) Revenue in Plasmid CDMO Services Business (2020-2025)
11.9.5 Obio Technology (Shanghai) Recent Development
11.10 Wacker Biotech US
11.10.1 Wacker Biotech US Company Details
11.10.2 Wacker Biotech US Business Overview
11.10.3 Wacker Biotech US Plasmid CDMO Services Introduction
11.10.4 Wacker Biotech US Revenue in Plasmid CDMO Services Business (2020-2025)
11.10.5 Wacker Biotech US Recent Development
11.11 Biovian
11.11.1 Biovian Company Details
11.11.2 Biovian Business Overview
11.11.3 Biovian Plasmid CDMO Services Introduction
11.11.4 Biovian Revenue in Plasmid CDMO Services Business (2020-2025)
11.11.5 Biovian Recent Development
11.12 Curia
11.12.1 Curia Company Details
11.12.2 Curia Business Overview
11.12.3 Curia Plasmid CDMO Services Introduction
11.12.4 Curia Revenue in Plasmid CDMO Services Business (2020-2025)
11.12.5 Curia Recent Development
11.13 Lotuslake Biomedical
11.13.1 Lotuslake Biomedical Company Details
11.13.2 Lotuslake Biomedical Business Overview
11.13.3 Lotuslake Biomedical Plasmid CDMO Services Introduction
11.13.4 Lotuslake Biomedical Revenue in Plasmid CDMO Services Business (2020-2025)
11.13.5 Lotuslake Biomedical Recent Development
11.14 VGXI
11.14.1 VGXI Company Details
11.14.2 VGXI Business Overview
11.14.3 VGXI Plasmid CDMO Services Introduction
11.14.4 VGXI Revenue in Plasmid CDMO Services Business (2020-2025)
11.14.5 VGXI Recent Development
11.15 Andelyn Biosciences
11.15.1 Andelyn Biosciences Company Details
11.15.2 Andelyn Biosciences Business Overview
11.15.3 Andelyn Biosciences Plasmid CDMO Services Introduction
11.15.4 Andelyn Biosciences Revenue in Plasmid CDMO Services Business (2020-2025)
11.15.5 Andelyn Biosciences Recent Development
11.16 Esco Aster
11.16.1 Esco Aster Company Details
11.16.2 Esco Aster Business Overview
11.16.3 Esco Aster Plasmid CDMO Services Introduction
11.16.4 Esco Aster Revenue in Plasmid CDMO Services Business (2020-2025)
11.16.5 Esco Aster Recent Development
11.17 BioCina
11.17.1 BioCina Company Details
11.17.2 BioCina Business Overview
11.17.3 BioCina Plasmid CDMO Services Introduction
11.17.4 BioCina Revenue in Plasmid CDMO Services Business (2020-2025)
11.17.5 BioCina Recent Development
11.18 Merck
11.18.1 Merck Company Details
11.18.2 Merck Business Overview
11.18.3 Merck Plasmid CDMO Services Introduction
11.18.4 Merck Revenue in Plasmid CDMO Services Business (2020-2025)
11.18.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Plasmid CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of IIT Grade
Table 3. Key Players of IND Grade
Table 4. Key Players of Clinical Trial Grade
Table 5. Key Players of Commercial Production Grade
Table 6. Global Plasmid CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Plasmid CDMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Plasmid CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Plasmid CDMO Services Market Share by Region (2020-2025)
Table 10. Global Plasmid CDMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Plasmid CDMO Services Market Share by Region (2026-2031)
Table 12. Plasmid CDMO Services Market Trends
Table 13. Plasmid CDMO Services Market Drivers
Table 14. Plasmid CDMO Services Market Challenges
Table 15. Plasmid CDMO Services Market Restraints
Table 16. Global Plasmid CDMO Services Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Plasmid CDMO Services Market Share by Players (2020-2025)
Table 18. Global Top Plasmid CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid CDMO Services as of 2024)
Table 19. Ranking of Global Top Plasmid CDMO Services Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Plasmid CDMO Services Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Plasmid CDMO Services, Headquarters and Area Served
Table 22. Global Key Players of Plasmid CDMO Services, Product and Application
Table 23. Global Key Players of Plasmid CDMO Services, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Plasmid CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Plasmid CDMO Services Revenue Market Share by Type (2020-2025)
Table 27. Global Plasmid CDMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Plasmid CDMO Services Revenue Market Share by Type (2026-2031)
Table 29. Global Plasmid CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Plasmid CDMO Services Revenue Market Share by Application (2020-2025)
Table 31. Global Plasmid CDMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Plasmid CDMO Services Revenue Market Share by Application (2026-2031)
Table 33. North America Plasmid CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Plasmid CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Plasmid CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Plasmid CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Plasmid CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Plasmid CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Plasmid CDMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Plasmid CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Plasmid CDMO Services Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Plasmid CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Plasmid CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Plasmid CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Plasmid CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Plasmid CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Plasmid CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 48. GenScript ProBio Company Details
Table 49. GenScript ProBio Business Overview
Table 50. GenScript ProBio Plasmid CDMO Services Product
Table 51. GenScript ProBio Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 52. GenScript ProBio Recent Development
Table 53. PackGene Biotech Company Details
Table 54. PackGene Biotech Business Overview
Table 55. PackGene Biotech Plasmid CDMO Services Product
Table 56. PackGene Biotech Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 57. PackGene Biotech Recent Development
Table 58. Hillgene Company Details
Table 59. Hillgene Business Overview
Table 60. Hillgene Plasmid CDMO Services Product
Table 61. Hillgene Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 62. Hillgene Recent Development
Table 63. Porton Advanced Solutions Company Details
Table 64. Porton Advanced Solutions Business Overview
Table 65. Porton Advanced Solutions Plasmid CDMO Services Product
Table 66. Porton Advanced Solutions Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 67. Porton Advanced Solutions Recent Development
Table 68. Catalent Company Details
Table 69. Catalent Business Overview
Table 70. Catalent Plasmid CDMO Services Product
Table 71. Catalent Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 72. Catalent Recent Development
Table 73. VectorBuilder Company Details
Table 74. VectorBuilder Business Overview
Table 75. VectorBuilder Plasmid CDMO Services Product
Table 76. VectorBuilder Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 77. VectorBuilder Recent Development
Table 78. Ubrigene Company Details
Table 79. Ubrigene Business Overview
Table 80. Ubrigene Plasmid CDMO Services Product
Table 81. Ubrigene Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 82. Ubrigene Recent Development
Table 83. Charles River Laboratories Company Details
Table 84. Charles River Laboratories Business Overview
Table 85. Charles River Laboratories Plasmid CDMO Services Product
Table 86. Charles River Laboratories Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 87. Charles River Laboratories Recent Development
Table 88. Obio Technology (Shanghai) Company Details
Table 89. Obio Technology (Shanghai) Business Overview
Table 90. Obio Technology (Shanghai) Plasmid CDMO Services Product
Table 91. Obio Technology (Shanghai) Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 92. Obio Technology (Shanghai) Recent Development
Table 93. Wacker Biotech US Company Details
Table 94. Wacker Biotech US Business Overview
Table 95. Wacker Biotech US Plasmid CDMO Services Product
Table 96. Wacker Biotech US Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 97. Wacker Biotech US Recent Development
Table 98. Biovian Company Details
Table 99. Biovian Business Overview
Table 100. Biovian Plasmid CDMO Services Product
Table 101. Biovian Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 102. Biovian Recent Development
Table 103. Curia Company Details
Table 104. Curia Business Overview
Table 105. Curia Plasmid CDMO Services Product
Table 106. Curia Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 107. Curia Recent Development
Table 108. Lotuslake Biomedical Company Details
Table 109. Lotuslake Biomedical Business Overview
Table 110. Lotuslake Biomedical Plasmid CDMO Services Product
Table 111. Lotuslake Biomedical Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 112. Lotuslake Biomedical Recent Development
Table 113. VGXI Company Details
Table 114. VGXI Business Overview
Table 115. VGXI Plasmid CDMO Services Product
Table 116. VGXI Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 117. VGXI Recent Development
Table 118. Andelyn Biosciences Company Details
Table 119. Andelyn Biosciences Business Overview
Table 120. Andelyn Biosciences Plasmid CDMO Services Product
Table 121. Andelyn Biosciences Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 122. Andelyn Biosciences Recent Development
Table 123. Esco Aster Company Details
Table 124. Esco Aster Business Overview
Table 125. Esco Aster Plasmid CDMO Services Product
Table 126. Esco Aster Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 127. Esco Aster Recent Development
Table 128. BioCina Company Details
Table 129. BioCina Business Overview
Table 130. BioCina Plasmid CDMO Services Product
Table 131. BioCina Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 132. BioCina Recent Development
Table 133. Merck Company Details
Table 134. Merck Business Overview
Table 135. Merck Plasmid CDMO Services Product
Table 136. Merck Revenue in Plasmid CDMO Services Business (2020-2025) & (US$ Million)
Table 137. Merck Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report


List of Figures
Figure 1. Plasmid CDMO Services Picture
Figure 2. Global Plasmid CDMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Plasmid CDMO Services Market Share by Type: 2024 VS 2031
Figure 4. IIT Grade Features
Figure 5. IND Grade Features
Figure 6. Clinical Trial Grade Features
Figure 7. Commercial Production Grade Features
Figure 8. Global Plasmid CDMO Services Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Plasmid CDMO Services Market Share by Application: 2024 VS 2031
Figure 10. Biopharmaceutical Company Case Studies
Figure 11. Academic Scientific Research Institution Case Studies
Figure 12. Plasmid CDMO Services Report Years Considered
Figure 13. Global Plasmid CDMO Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Plasmid CDMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Plasmid CDMO Services Market Share by Region: 2024 VS 2031
Figure 16. Global Plasmid CDMO Services Market Share by Players in 2024
Figure 17. Global Top Plasmid CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid CDMO Services as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Plasmid CDMO Services Revenue in 2024
Figure 19. North America Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Plasmid CDMO Services Market Share by Country (2020-2031)
Figure 21. United States Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Plasmid CDMO Services Market Share by Country (2020-2031)
Figure 25. Germany Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Plasmid CDMO Services Market Share by Region (2020-2031)
Figure 33. China Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Plasmid CDMO Services Market Share by Country (2020-2031)
Figure 41. Mexico Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Plasmid CDMO Services Market Share by Country (2020-2031)
Figure 45. Turkey Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Plasmid CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. GenScript ProBio Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 49. PackGene Biotech Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 50. Hillgene Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 51. Porton Advanced Solutions Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 52. Catalent Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 53. VectorBuilder Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 54. Ubrigene Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 55. Charles River Laboratories Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 56. Obio Technology (Shanghai) Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 57. Wacker Biotech US Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 58. Biovian Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 59. Curia Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 60. Lotuslake Biomedical Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 61. VGXI Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 62. Andelyn Biosciences Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 63. Esco Aster Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 64. BioCina Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 65. Merck Revenue Growth Rate in Plasmid CDMO Services Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies